Capital World Investors’s Precision BioSciences DTIL Stock Holding History

Capital World Investors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-170,649	Closed	-$1.87M	–	522
2023 Q4	$1.87M	Sell	170,649 -53,186	-24%	-$573K	﹤0.01%	485
2023 Q3	$2.29M	Hold	223,835	–	–	﹤0.01%	489
2023 Q2	$3.53M	Hold	223,835	–	–	﹤0.01%	471
2023 Q1	$5.06M	Hold	223,835	–	–	﹤0.01%	474
2022 Q4	$7.99M	Hold	223,835	–	–	﹤0.01%	490
2022 Q3	$8.73M	Hold	223,835	–	–	﹤0.01%	494
2022 Q2	$10.7M	Buy	223,835 +81,535	+57%	+$4.79M	﹤0.01%	494
2022 Q1	$13.1M	Hold	142,300	–	–	﹤0.01%	513
2021 Q4	$31.6M	Hold	142,300	–	–	0.01%	494
2021 Q3	$49.3M	Hold	142,300	–	–	0.01%	443
2021 Q2	$53.4M	Buy	142,300 +6,900	+5%	+$2.07M	0.01%	441
2021 Q1	$42M	Hold	135,400	–	–	0.01%	456
2020 Q4	$33.9M	Hold	135,400	–	–	0.01%	449
2020 Q3	$25M	Hold	135,400	–	–	0.01%	448
2020 Q2	$33.8M	Hold	135,400	–	–	0.01%	390
2020 Q1	$24.5M	Hold	135,400	–	–	0.01%	377
2019 Q4	$56.4M	Buy	135,400 +114,567	+550%	+$36M	0.01%	345
2019 Q3	$5.24M	Hold	20,833	–	–	﹤0.01%	493
2019 Q2	$8.28M	Hold	20,833	–	–	﹤0.01%	496
2019 Q1	$11.2M	Buy	+20,833	New	+$11.1M	﹤0.01%	476

Other funds holding DTIL

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Capital World Investors's DTIL Position: Q1 2024 in Review

Capital World Investors sold out of Precision BioSciences (DTIL) in Q1 2024, closing a stake of 170,649 shares — an estimated $1.87M sold.

Capital World Investors first reported a position in DTIL in Q1 2019 and held it in 20 quarters. The position peaked at $56.4M in Q4 2019. 43 funds tracked by Wall St. Rank hold DTIL as of Q1 2024.

Capital World Investors reported no remaining Precision BioSciences position as of Q1 2024 after selling out during the quarter.
Capital World Investors sold 170,649 Precision BioSciences shares in Q1 2024, an estimated $1.87M.
Capital World Investors first reported a position in Precision BioSciences in Q1 2019 and held it in 20 quarters.
Capital World Investors's Precision BioSciences position peaked at $56.4M in Q4 2019.
43 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2024.

Based on Capital World Investors's 13F filing for Q1 2024, filed 14 May 2024.